The Latest Headlines at American Banking and Market News
MidWestOne Financial Group (NASDAQ:MOFG) PT Lowered to $22.00
MidWestOne Financial Group (NASDAQ:MOFG – Get Free Report) had its price target cut by stock analysts at Piper Sandler from $24.00 to $22.00 in a note issued to investors on Monday, Benzinga reports. The firm presently has a... More of this article »
Lululemon Athletica (NASDAQ:LULU) Rating Lowered to Equal Weight at Barclays
Lululemon Athletica (NASDAQ:LULU – Get Free Report) was downgraded by equities researchers at Barclays from an “overweight” rating to an “equal weight” rating in a research report issued to clients and... More of this article »
Old Dominion Freight Line (NASDAQ:ODFL) Stock Rating Upgraded by Vertical Research
Old Dominion Freight Line (NASDAQ:ODFL – Get Free Report) was upgraded by research analysts at Vertical Research from a “sell” rating to a “hold” rating in a research note issued on Monday, Marketbeat... More of this article »
Macatawa Bank (NASDAQ:MCBC) Stock Rating Upgraded by Keefe, Bruyette & Woods
Macatawa Bank (NASDAQ:MCBC – Get Free Report) was upgraded by stock analysts at Keefe, Bruyette & Woods from a “market perform” rating to an “outperform” rating in a research report issued to clients... More of this article »
Stephens Upgrades W.W. Grainger (NYSE:GWW) to Overweight
W.W. Grainger (NYSE:GWW – Get Free Report) was upgraded by research analysts at Stephens from an “equal weight” rating to an “overweight” rating in a research report issued on Monday, MarketBeat reports.... More of this article »
Terns Pharmaceuticals (NASDAQ:TERN) Given “Market Outperform” Rating at JMP Securities
JMP Securities reaffirmed their market outperform rating on shares of Terns Pharmaceuticals (NASDAQ:TERN – Free Report) in a report released on Tuesday, Benzinga reports. JMP Securities currently has a $15.00 price target on... More of this article »
Terns Pharmaceuticals (NASDAQ:TERN) Receives “Neutral” Rating from HC Wainwright
HC Wainwright reissued their neutral rating on shares of Terns Pharmaceuticals (NASDAQ:TERN – Free Report) in a research report report published on Tuesday, Benzinga reports. They currently have a $5.50 price target on the stock. A... More of this article »
LendingTree (NASDAQ:TREE) Price Target Increased to $56.00 by Analysts at Needham & Company LLC
LendingTree (NASDAQ:TREE – Free Report) had its target price boosted by Needham & Company LLC from $40.00 to $56.00 in a research report report published on Tuesday morning, Benzinga reports. They currently have a buy rating... More of this article »
UMB Financial (NASDAQ:UMBF) Price Target Raised to $93.00 at Keefe, Bruyette & Woods
UMB Financial (NASDAQ:UMBF – Free Report) had its target price boosted by Keefe, Bruyette & Woods from $86.00 to $93.00 in a research report report published on Tuesday morning, Benzinga reports. Keefe, Bruyette & Woods... More of this article »
TrueCar (NASDAQ:TRUE) Given New $4.00 Price Target at Needham & Company LLC
TrueCar (NASDAQ:TRUE – Free Report) had its price objective trimmed by Needham & Company LLC from $4.50 to $4.00 in a research note issued to investors on Tuesday morning, Benzinga reports. The firm currently has a buy rating... More of this article »
Tetra Tech (NASDAQ:TTEK) Given New $230.00 Price Target at Maxim Group
Tetra Tech (NASDAQ:TTEK – Free Report) had its price objective boosted by Maxim Group from $220.00 to $230.00 in a research note released on Tuesday, Benzinga reports. The brokerage currently has a buy rating on the industrial... More of this article »
UMB Financial (NASDAQ:UMBF) Given New $90.00 Price Target at Wells Fargo & Company
UMB Financial (NASDAQ:UMBF – Free Report) had its price target boosted by Wells Fargo & Company from $88.00 to $90.00 in a report released on Tuesday, Benzinga reports. The brokerage currently has an equal weight rating... More of this article »
GeneDx (NASDAQ:WGS) Price Target Increased to $19.00 by Analysts at BTIG Research
GeneDx (NASDAQ:WGS – Free Report) had its price objective increased by BTIG Research from $15.00 to $19.00 in a report released on Tuesday, Benzinga reports. They currently have a buy rating on the stock. Separately, The Goldman... More of this article »